🔎 Trials Near Me

홈 › 크론병 › 인디애나

인디애나의 크론병 임상 시험

크론병 관련 연구 13개가 인디애나 내 여러 지역에서 참여자를 모집하고 있습니다.

인디애나의 도시

공식 연구 텍스트(영어)

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Indiana University Health University Hospital ( Site 5022), Indianapolis
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06430801

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Indiana University Health University Hospital, Indianapolis
  • Gastroenterology Health Partners, New Albany
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06937099

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • IU Health University Hospital, Indianapolis
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07196722

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  • Riley Hospital for Children, Indianapolis
피험자 모집 중3상
3세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06663332

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Riley Hospital for Children, Indianapolis
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT05923073

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Riverview Health, Westfield
피험자 모집 중4상
18세 ~ 80세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT06581328

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Gastroenterology Health Partners /ID# 284145, New Albany
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07697456

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100, New Albany
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07184944

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100, New Albany
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Indiana University Health Riley Hospital for Children /ID# 256454, Indianapolis
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 20. 업데이트됨 · NCT05995353

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Riley Childrens Hospital, Indianapolis
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT05509777

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Indiana University Health University Hospital /ID# 278129, Indianapolis
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06548542

Precise Infliximab Exposure and Pharmacodynamic Control

  • Riley Hospital for Children, Indianapolis
피험자 모집 중2/3상
6세 ~ 22세 · 모든 성별 · 2026. 5. 5. 업데이트됨 · NCT05660746

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.